Zacks Investment Research upgraded IntriCon Corporation (NASDAQ:IIN) to Hold in a report released today.
- Updated: October 9, 2016
Zacks Investment Research has upgraded IntriCon Corporation (NASDAQ:IIN) to Hold in a statement released on 10/05/2016.
Boasting a price of $6.14, IntriCon Corporation (NASDAQ:IIN) traded 6.04% higher on the day. With the last stock price close up 14.80% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. IIN has recorded a 50-day average of $5.01 and a two hundred day average of $5.35. Trade Volume was down over the average, with 976 shares of IIN changing hands under the typical 11,035
With a total market value of $0, IntriCon Corporation has with a one year low of $4.12 and a one year high of $8.65 .
More About IntriCon Corporation (NASDAQ:IIN)
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market. The Company has facilities in Minnesota, California, Singapore, Indonesia, the United Kingdom and Germany, and operates through its subsidiaries. The Company's product offering includes a hearing aid discount program for health plans. This program is available around the nation to health insurers, including employer-sponsored, individual and Medicare plans. The Company also has various international value hearing aid (VHA) initiatives.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.